FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065157028> ?p ?o ?g. }

• W2065157028 endingPage "84" @default.
• W2065157028 startingPage "76" @default.
• W2065157028 abstract "Abstract BACKGROUND There have been several epidemiologic studies investigating the association between circulating levels of insulin‐like growth factor I (IGF‐I), insulin‐like growth factor binding protein 3 (IGFBP‐3), and insulin in relation to the risk of prostate carcinoma, with conflicting results. To examine this issue further, the authors conducted a nested case–control study within the Cardiovascular Health Study cohort. METHODS In men who were diagnosed with prostate carcinoma (cases) between 1990 and 1999 ( n = 174), the levels of IGF‐I, IGFBP‐3, and insulin were measured on blood samples that were obtained 1–9 years prior to diagnosis (mean, 3.4 years). Similar measurements were made on 174 male participants without prostate carcinoma (controls) who were matched to cases based on the year blood was drawn, survival until the date of diagnosis, race, and age. RESULTS Relative to the men with IGF‐I levels in the first (lowest) quartile of the distribution, the risk of prostate carcinoma for men in the second, third, and fourth (upper) quartiles were 0.77 (95% confidence interval [95% CI], 0.43–1.38), 0.73 (95% CI, 0.41–1.30), and 0.67 (95% CI, 0.37–1.25), respectively. The results were influenced little by adjustment for levels of IGFBP‐3 or, instead, by evaluating the molar IGF‐I/IGFBP‐3 ratio. An analysis that was restricted to men who had plasma prostate‐specific antigen levels < 4 ng/mL at the time of the blood draw yielded similar results. The corresponding relative risks for IGFBP‐3 were 0.91 (95% CI, 0.49–1.68), 0.47 (95% CI, 0.25–0.94), and 0.65 (95% CI, 0.35–1.20), respectively. The distribution of serum insulin levels in cases and controls were nearly identical. CONCLUSIONS The IGF‐I level was not associated positively with the risk of prostate carcinoma; however, an increase in the IGFBP‐3 level was associated with a modest decrease in risk. Cancer 2005. © 2004 American Cancer Society." @default.
• W2065157028 created "2016-06-24" @default.
• W2065157028 creator A5016958524 @default.
• W2065157028 creator A5040963322 @default.
• W2065157028 creator A5061502641 @default.
• W2065157028 creator A5070515648 @default.
• W2065157028 creator A5071161054 @default.
• W2065157028 creator A5090374110 @default.
• W2065157028 date "2004-11-11" @default.
• W2065157028 modified "2023-10-18" @default.
• W2065157028 title "Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin" @default.
• W2065157028 cites W1873738835 @default.
• W2065157028 cites W1970373365 @default.
• W2065157028 cites W1993194661 @default.
• W2065157028 cites W2012505775 @default.
• W2065157028 cites W2020636054 @default.
• W2065157028 cites W2042842503 @default.
• W2065157028 cites W2044826176 @default.
• W2065157028 cites W2047443262 @default.
• W2065157028 cites W2050959330 @default.
• W2065157028 cites W2056854271 @default.
• W2065157028 cites W2056965752 @default.
• W2065157028 cites W2058496290 @default.
• W2065157028 cites W2063131612 @default.
• W2065157028 cites W2070769230 @default.
• W2065157028 cites W2072976646 @default.
• W2065157028 cites W2090140552 @default.
• W2065157028 cites W2092978866 @default.
• W2065157028 cites W2100528017 @default.
• W2065157028 cites W2105491559 @default.
• W2065157028 cites W2107837604 @default.
• W2065157028 cites W2122110999 @default.
• W2065157028 cites W2151765511 @default.
• W2065157028 cites W2156982018 @default.
• W2065157028 cites W2159318197 @default.
• W2065157028 cites W2161197885 @default.
• W2065157028 cites W2169049560 @default.
• W2065157028 cites W4230472375 @default.
• W2065157028 cites W4232158671 @default.
• W2065157028 cites W4234019287 @default.
• W2065157028 cites W4235939342 @default.
• W2065157028 cites W4238200941 @default.
• W2065157028 cites W4239037509 @default.
• W2065157028 cites W4240656952 @default.
• W2065157028 cites W4242280461 @default.
• W2065157028 cites W4242571193 @default.
• W2065157028 cites W4248903045 @default.
• W2065157028 cites W4255932238 @default.
• W2065157028 cites W4321060065 @default.
• W2065157028 doi "https://doi.org/10.1002/cncr.20727" @default.
• W2065157028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15540247" @default.
• W2065157028 hasPublicationYear "2004" @default.
• W2065157028 type Work @default.
• W2065157028 sameAs 2065157028 @default.
• W2065157028 citedByCount "84" @default.
• W2065157028 countsByYear W20651570282012 @default.
• W2065157028 countsByYear W20651570282013 @default.
• W2065157028 countsByYear W20651570282014 @default.
• W2065157028 countsByYear W20651570282015 @default.
• W2065157028 countsByYear W20651570282016 @default.
• W2065157028 countsByYear W20651570282017 @default.
• W2065157028 countsByYear W20651570282018 @default.
• W2065157028 countsByYear W20651570282019 @default.
• W2065157028 countsByYear W20651570282020 @default.
• W2065157028 countsByYear W20651570282021 @default.
• W2065157028 countsByYear W20651570282022 @default.
• W2065157028 crossrefType "journal-article" @default.
• W2065157028 hasAuthorship W2065157028A5016958524 @default.
• W2065157028 hasAuthorship W2065157028A5040963322 @default.
• W2065157028 hasAuthorship W2065157028A5061502641 @default.
• W2065157028 hasAuthorship W2065157028A5070515648 @default.
• W2065157028 hasAuthorship W2065157028A5071161054 @default.
• W2065157028 hasAuthorship W2065157028A5090374110 @default.
• W2065157028 hasBestOaLocation W20651570281 @default.
• W2065157028 hasConcept C121608353 @default.
• W2065157028 hasConcept C126322002 @default.
• W2065157028 hasConcept C134018914 @default.
• W2065157028 hasConcept C143998085 @default.
• W2065157028 hasConcept C170493617 @default.
• W2065157028 hasConcept C2775960820 @default.
• W2065157028 hasConcept C2776235491 @default.
• W2065157028 hasConcept C2777546739 @default.
• W2065157028 hasConcept C2779306644 @default.
• W2065157028 hasConcept C2780192828 @default.
• W2065157028 hasConcept C2780689927 @default.
• W2065157028 hasConcept C2781406297 @default.
• W2065157028 hasConcept C44249647 @default.
• W2065157028 hasConcept C50440223 @default.
• W2065157028 hasConcept C68443243 @default.
• W2065157028 hasConcept C71924100 @default.
• W2065157028 hasConcept C72563966 @default.
• W2065157028 hasConcept C82789193 @default.
• W2065157028 hasConceptScore W2065157028C121608353 @default.
• W2065157028 hasConceptScore W2065157028C126322002 @default.
• W2065157028 hasConceptScore W2065157028C134018914 @default.
• W2065157028 hasConceptScore W2065157028C143998085 @default.
• W2065157028 hasConceptScore W2065157028C170493617 @default.
• W2065157028 hasConceptScore W2065157028C2775960820 @default.

• next